Zanella Zanella

Dr. Zanella Zanella


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SGSummer Fever Study Group
Summer Fever Study Group
FGFederico Gobbi
Federico Gobbi
GCGioia Capelli
Gioia Capelli
AAAndrea Angheben
Andrea Angheben
MGMario Giobbia
Mario Giobbia
ZBZeno Bisoffi
Zeno Bisoffi
Since 2010 Veneto region (North-Eastern Italy) planned a special integrated surveillance of summer fevers to promptly identify cases of West Nile Fever (WNF), dengue (DENV) and chikungunya (CHIKV). The objectives of this study were (i) To increase the detection rate of imported CHIKV and DENV cases in travellers from endemic areas and promptly identify potential autochthonous cases.(ii) To detect autochthonous cases of WNF, besides those of West Nile Neuroinvasive Disease (WNND) that were already included in a national surveillance.

1 March 2021 in Ticks and Tick-borne Diseases
Verified
Journal Article
Open access
ABAnna Beltrame
Anna Beltrame
PRPaola Rodari
Paola Rodari
LMLuisa Mauroner
Luisa Mauroner
ZZZanella Zanella
Zanella Zanella
LMLucia Moro
Lucia Moro
Ronaldo SilvaRonaldo Silva
Ronaldo Silva
We investigated the epidemiology, clinical manifestations, laboratory data and antibiotic treatment of Lyme borreliosis in the province of Verona, Northern Italy, during the period 2015-2019. One hundred and 29 cases of Lyme borreliosis were diagnosed in a single hospital representing 27 % of all cases reported in the Veneto region in the same period. The mean annual incidence of Lyme borreliosis was 0.992/100,000 inhabitants. A peak incidence of 2/100,000 inhabitants was observed in 2018. Early localized Lyme borreliosis was the most common presentation (74 %), followed by early disseminated Lyme borreliosis (21 %). One possible early Lyme neuroborreliosis and two cranial neuropathies were diagnosed. IgM and/or IgG borrelia antibodies were positive in 90 % of the cases. This significant increase of Lyme borreliosis incidence in the province of Verona highlights the need to increase knowledge on its epidemiology and clinical manifestation among both the general population and clinicians to allow early diagnosis and treatment.

16 February 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
MTMichele Tonon
Michele Tonon
SPStefan-Alexandru Panaite
Stefan-Alexandru Panaite
DGDavide Gentili
Davide Gentili
AFAnna Ferraresso
Anna Ferraresso
FRFilippo Da Re
Filippo Da Re
Vincenzo BaldoVincenzo Baldo
Vincenzo Baldo
The recent increase in parvovirus B19 (B19V) infections across Europe has underscored the need for enhanced surveillance. In Italy, B19V surveillance is not mandated nationally. This ambispective (retrospective and prospective) study aimed to assess the epidemiological and clinical characteristics of the 2024 apparent surge in the Veneto Region by implementing mandatory disease notification starting in May 2024 and collecting clinical data on confirmed cases. During the surveillance period, 3156 B19V cases were reported, with 2.9% (93/3156) requiring hospitalisation (95% CI 2.4–3.5%). Children under 1 year of age exhibited the highest hospitalisation rate (29.0%), followed by adults aged 18–40 (17.5%). Infections disproportionately affected children aged 1–5 and 6–11, and the Granger causality test showed that an increase in cases among the 1–5-year-olds was predictive of subsequent rises in other age groups (p = 0.0086). Severe complications, including myocarditis, pericarditis, and miscarriage, were observed, and one death occurred following cardiac and neurological complications in a patient without prior risk factors. The presence of concurrent pathologies, particularly haematological disorders, was associated with increased disease severity. These findings highlight the importance of early warning when cases begin rising among preschool-aged children and underscore the need for improved B19V awareness, particularly in high-risk populations. Future efforts should evaluate the feasibility of implementing a systematic, potentially EU-wide, surveillance for B19V.

24 February 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
SCSilvia Cocchio
Silvia Cocchio
CCClaudia Cozzolino
Claudia Cozzolino
ACAndrea Cozza
Andrea Cozza
PFPatrizia Furlan
Patrizia Furlan
EFEnrica Frasson
Enrica Frasson
Vincenzo BaldoVincenzo Baldo
Vincenzo Baldo
Introduction: Invasive bacterial diseases (IBDs) such as meningitis and sepsis are significant public health concerns, particularly in pediatric populations. This study analyzes the incidence, outcomes, and bacterial serotype distribution of pediatric IBDs in the Veneto Region over 17 years. Methods: An observational study was conducted using data (2007–2023) from the surveillance system of the Veneto Region, including microbiologically confirmed cases in individuals < 18 years. Differences by age groups and trends were statistically assessed. Results: A total of 535 pediatric IBD cases were reported, with Streptococcus pneumoniae (54.6%), Neisseria meningitidis (19.6%), and Streptococcus agalactiae (13.5%) being the most common pathogens. Haemophilus influenzae infections were more commonly represented in infants under 1 year (41.5%), whereas S. pneumoniae and N. meningitidis were more frequent in the 1–4-year age group (40.8% and 37.1%, respectively). Sepsis was the most common clinical presentation (57.2%), followed by meningitis (36.3%). Serotype analysis revealed that S. pneumoniae serotype 3 was the most prevalent, while serogroup B dominated N. meningitidis cases. Temporal trends generally showed a decline in cases until 2019, a drop during the COVID-19 pandemic, and a subsequent resurgence in 2022–2023. Conclusions: Our research underscores the value of evidence-based epidemiology through robust surveillance systems in tracking IBD trends and serotype shifts, essential for guiding vaccination strategies and public health interventions. These insights highlight the effectiveness of vaccination programs and the necessity of ongoing monitoring to inform public health policies. Improved data integration and completeness are recommended to enhance surveillance accuracy.

23 October 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
SCSilvia Cocchio
Silvia Cocchio
CCClaudia Cozzolino
Claudia Cozzolino
ACAndrea Cozza
Andrea Cozza
PFPatrizia Furlan
Patrizia Furlan
Irene AmorusoIrene Amoruso
Irene Amoruso
Vincenzo BaldoVincenzo Baldo
Vincenzo Baldo
Background: Elderly individuals over 65, along with children under 5, are the most affected by invasive pneumococcal diseases (IPDs). Monitoring vaccination coverage and conducting surveillance are essential for guiding evidence-based prevention campaigns and public health measures. Methods: Since 2007, the Veneto Region has relied on three sources for surveillance of invasive bacterial infections, contributing to an increase in reported IPD cases. This study analyzed notifications related to individuals aged ≥65 years from 2007 to 2023. Results: A total of 1527 cases of IPDs in elderly individuals were reported between 2007 and 2023. The notification rate significantly increased from 5.61 to 14.63 per 100,000 inhabitants, despite underreporting during the COVID-19 pandemic. Cases associated with sepsis increased from 3.89 to 9.58 per 100,000, while notifications of meningitis and case fatality rates remained stable at 1.5 per 100,000 and 11.8%, respectively. Serotyping was not performed in 52% of the notifications. The most common serotypes were 3 (21.6%), 8 (11.1%), and 19A (5.0%), with fluctuations over time. There was a significant decline in serotypes covered by PCV7 and PCV13 and an increase in non-vaccine serotypes. Conclusions: The regional surveillance system allows for an increasingly comprehensive profile of the epidemiological landscape of IPDs in Veneto. However, the surveillance of pneumococcal infections still presents challenges. The currently available data are likely to be underestimated, mainly referring to the most severe cases, and the serotyping necessary to identify the etiological agent is still not often performed.

16 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MTMichele Tonon
Michele Tonon
SPStefan-Alexandru Panaite
Stefan-Alexandru Panaite
DGDavide Gentili
Davide Gentili
AFAnna Ferraresso
Anna Ferraresso
FRFilippo Da Re
Filippo Da Re
Vincenzo BaldoVincenzo Baldo
Vincenzo Baldo
The recent increase in parvovirus B19 (B19V) infections across Europe has underscored the need for enhanced surveillance. In Italy, where B19V surveillance is not mandated nationally, this study aimed to assess the epidemiological and clinical characteristics of the outbreak in the Veneto Region by implementing mandatory disease notification since May 2024 and collecting clinical data on confirmed cases. The outbreak disproportionately affected young children, with the highest incidence in the 1-5 and 6-11 age groups. The increase in cases within the 1-5 year age group was predictive of an increase in cases in other age groups. Hospitalisation was required in a small percentage of cases, but severe complications, including myocarditis, pericarditis, and miscarriage, were observed, underscoring the potential severity of B19V infection. During the surveillance period, one death was also recorded following cardiac and neurological complications in a patient without prior risk factors. The presence of concurrent pathologies, particularly haematological disorders, was associated with increased disease severity. This study emphasises the critical need for improved awareness of B19V, particularly in high-risk populations, and highlights the importance of early warning when cases start rising among 1-5-year-olds. The feasibility of implementing a systematic and potentially EU-wide surveillance system for B19V should be assessed.